Navigation Links
Joint Statement on Atypical Antipsychotic Use in Children
Date:6/8/2009

WASHINGTON, June 8 /PRNewswire-USNewswire/ -- The below listed groups issued the following statement regarding the upcoming FDA Psychopharmacologic Drugs Advisory Committee Meeting on June 9-10:

As advocates for people living with mental illnesses, we strongly urge the FDA to carefully consider the importance of viable treatment options for bipolar disorder and schizophrenia in pediatric and adolescent populations. Access to safe and effective treatments, including more information about all treatment options, is crucial to treating these serious and complex conditions in children and adolescents.

Bipolar disorder and schizophrenia are very real, life-threatening diseases which can appear in childhood and adolescence. For example, federally funded research (STEP-BD) found that, of 3,658 adult patients studied, 68% reported bipolar disease onset in childhood or adolescence. Patients with child onset had, on average, fewer days of euthymia (or neutral mood), greater impairment in functioning and poorer quality of life. Those with adolescent onset have better outcomes than those with child onset, but were still worse off than those who did not suffer from bipolar disorder until adulthood. These alarming statistics highlight the need for early recognition and treatment, which offers children and adolescents their best chance to achieve and maintain wellness.

We encourage an open and transparent scientific discourse about all pharmacologic treatments that come before the Advisory Committee and urge the Committee to carefully weigh the available evidence regarding safety and efficacy. No one treatment option works for all children. In order for physicians and families to make informed treatment decisions they need access to a full range of medications and treatment options and to the research regarding the risks and benefits of these treatments. More long-term clinical research in children and adolescents is also needed to better understand the risks and benefits of these medications when used over an extended period.

As we know, these medications can also have serious side effects, which is why it is crucial that parents and physicians have as much information as possible in order to make informed decisions and weigh the risk of side effects and adverse reactions against the risk of not treating these very serious diseases. Other treatments for grave childhood illnesses such as cancer can cause hair loss, nausea, compromised immune systems and even death. However, few people question the necessity of these aggressive forms of treatment. Like cancer, aggressive treatment may be needed for some patients with bipolar disorder and schizophrenia, diseases with a higher risk of death than some forms of cancer.

The best way to protect the health of our nation's children and adolescents is to increase access to treatment options and communicate accurate, scientific information that helps parents and physicians cope with and properly treat these devastating illnesses.

Our non-profit national mental health advocacy and medical professional organizations represent consumers, physicians, researchers and the top experts in the field of mental health and neuroscience. For more information about mental illness and treatment, we recommend that you talk to your health care provider or visit our organization websites.

American Academy of Child and Adolescent Psychiatry - www.aacap.org

American Foundation for Suicide Prevention - www.afsp.org

American Psychiatric Association - www.psych.org

Child and Adolescent Bipolar Foundation - www.bpkids.org

Children and Adults with Attention-Deficit/Hyperactivity Disorder - www.chadd.org

Families for Depression Awareness - www.familyaware.org

Mental Health America - www.mentalhealthamerica.net

National Alliance on Mental Illness - www.nami.org

National Council for Community Behavioral Healthcare - http://www.thenationalcouncil.org/


'/>"/>
SOURCE Mental Health America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
2. ASH and EHA jointly announce translational research training in hematology program
3. Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations
4. Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist
5. MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination
6. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
7. Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administrations FY 2010 Budget
8. Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
9. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
10. Joint Commission Awards TeamHealth Teleradiology Second Consecutive Gold Seal of Approval(TM)
11. Specialists On Call Renews Joint Commission Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... , ... September 22, 2017 , ... ... you brush more effectively even on the go. Their electric toothbrushes aggressively attack ... gum inflammation, with UV sanitizing technology. Combining leading edge Enke technology with a ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... Lyme and other tick-borne diseases through research, education and awareness, today announced the ... A noted immunologist and microbiologist, Dr. Sellati has more than 20 years of ...
(Date:9/21/2017)... ... 21, 2017 , ... The American Addiction Treatment Association (AATA) ... in the addiction treatment industry entitled: Special Investigations Unit (SIU) – What ... state and federal governments are increasingly scrutinizing the addiction treatment industry for fraudulent ...
(Date:9/21/2017)... ... , ... In addition to sticking with the new years ... and use natural alternatives for all house cleaning products, disinfectants, respiratory relief, and ... the new line of essential oils, are all 100% organic and natural. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... A new ... recovery at a time when Virginia faces an opioid epidemic. , ... staggering increase of 38 percent from 2015, underscoring the need for additional addiction ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... WHIPPANY, N.J. , Sept. 1, 2017  Bayer will ... at the European Society for Medical Oncology (ESMO) 2017 Congress, ... studies presented will include new preclinical and clinical data on ... from two earlier pipeline projects. ... of the best minds in cancer research at ESMO," said ...
(Date:8/29/2017)... HAMPTON, Va. , Aug. 29, 2017 ivWatch, LLC, ... of peripheral IV infiltrations, announced it has been awarded an Innovative ... improvement company in the country. ... A continuous monitoring device to aid in the early detection of ... The ...
(Date:8/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will present at the Morgan ... New York . John Greisch , ... at 11:05 a.m. Eastern Time. The live ... recorded replay will be available one hour after the conclusion ... About Hill-Rom Holdings, Inc. ...
Breaking Medicine Technology: